The primary objective of this project is to study the (cost-)effectiveness of an online self-help training for fear of cancer recurrence. Online self-help for FCR is not expected to be effective for all participants. It is important to identify…
ID
Source
Brief title
Condition
- Other condition
- Anxiety disorders and symptoms
Synonym
Health condition
angst voor de terugkeer van kanker
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Primary outcome measure will be fear of cancer recurrence. Fear of cancer
recurrence will be assessed with the Fear of Cancer Recurrence Inventory
(FCRI). The FCRI consist of the following seven subscales: triggers, severity,
psychological distress, coping strategies, functioning impairments, insight,
and reassurance. The severity-subscale is the first outcome measure in this
study. The coping strategies- and functioning impairments-scale scores at
baseline will be used in the predictor analysis.
Secondary outcome
Secondary outcomes will be healthcare costs and psychological distress.
Healthcare costs will be assessed with the Medical Consumption Questionnaire
(MCQ) and the EuroQol-5D (EQ-5D). Psychological distress will be assessed with
the Fear of Cancer Recurrence Inventory (FCRI).
Other study parameters:
Baseline level of fear of recurrence severity, psychological distress, level of
functioning impairment, and coping strategies will be assessed with the Fear of
Cancer Recurrence Inventory (FCRI).
Psychosocial problems and risk factors will be assessed with the Psychosocial
Distress Questionnaire-Breast Cancer (PDQ-BC). The PDQ-BC consists of nine
subscales: trait anxiety, social support, state anxiety, depressive symptoms,
social problems, physical problems, body image, financial problems, and sexual
problems.
Self-efficacy will be assessed with an assembled questionnaire.
Background summary
The prevalence of patients living with breast cancer in the Netherlands has
been estimated to rise to 140.000 in 2020. One third of all women who have had
breast cancer suffer from fear of recurrence, which has a profound negative
impact on their quality of life. This fear may also lead to higher healthcare
costs and may compromise health outcomes. Breast cancer patients have indicated
that they lack support in dealing with their fear of cancer recurrence. In
light of the increasing prevalence of breast cancer and increasing health care
costs, we are in urgent need of a form of support that is both easily
accessible to a large group of patients and is cost-effective. Recently, an
online self-help training for fear of cancer recurrence was developed.
Study objective
The primary objective of this project is to study the (cost-)effectiveness of
an online self-help training for fear of cancer recurrence. Online self-help
for FCR is not expected to be effective for all participants. It is important
to identify factors that predict whether a person does or does not benefit from
treatment. This will be the second objective of this project.
Research questions
1. Is online self-help for fear of cancer recurrence (cost-) effective?
2. Can we predict for whom online self-help is beneficial?
Study design
The design of the study will be a multi-center, randomized-controlled trial,
comparing online self-help training with care as usual. Primary outcome measure
will be fear of cancer recurrence. Secondary outcome will be healthcare costs
and distress. Patients will be randomized to either the online self-help or
care as usual. Patients will be recruited through hospitals in various regions
in the Netherlands. Assessments will take place at baseline (T0), and 3 (T1), 9
(T2), 15 (T3) and 24 months later (T4).
Intervention
Participants start the training by filling out the Fear of Recurrence
Inventory, after which they get feedback about their scores and a suggestion
about which modules to follow.
The two basic modules concern:
1. Psycho-education about FCR, its symptoms and learning to recognize symptoms
of fear.
2. Teaching the basic principles of cognitive behavior therapy.
After these basic modules women can choose from the following 4 modules:
1. How to stop rumination, behavioral techniques to stop ruminating.
2. Action, making an action plan about what one can do when fear of recurrence
pops up.
3. Relax, audio files with relaxation practices.
4. Reassurance, how and when to seek reassurance.
Each module consists of an informative part and a practical part in which
participants are motivated to do exercises or assignments in daily life.
Participants are advised to take a week for each module they follow, so most
participants will need four to six weeks depending on how many modules they
follow. It is explained that the more time they invest, the more effect they
can expect from the training, but participants eventually choose themselves how
much time is actually spent on the training.
Study burden and risks
This study involves capacitated adults and therapeutic research. Participation
is free of charge. The pilot study indicates that no concrete risks are related
to the intervention. Participating in this study can be time consuming, as
participants will fill out several questionnaires at different time points.
These questionnaires contain questions that might be confronting for the
participant, as they confront the participant with her current situation.
Though, we do not expect this to be harmful.
Professor Bronkhorstlaan 20
Bilthoven 3723 MB
NL
Professor Bronkhorstlaan 20
Bilthoven 3723 MB
NL
Listed location countries
Age
Inclusion criteria
- Female
- Diagnosis of breast cancer, between one and five years ago (part A)
- No signs for local/regional recurrence or metastatic disease (part A)
- Capable of filling out questionnaires in Dutch (part A)
- Age at disease onset at least 18 years old (part A)
- Access to the internet (part B)
Exclusion criteria
- No exclusion criteria
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL45768.101.13 |